Page 3 - Nantahala Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nantahala capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nantahala Capital Today - Breaking & Trending Today

Two Rare Disease Drug Developers Raise Combined $152.5 Million in PIPE Offerings

Two Rare Disease Drug Developers Raise Combined $152.5 Million in PIPE Offerings
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Benitec Biopharma , Zura Bio , Rare Daily , Deep Track Capital , Great Point Partners , Suvretta Capital , Allostery Investments , Armistice Capital , Suvretta Capital Management , Adage Capital Partners , Nantahala Capital ,

Surrozen (SRZN) Announces $192.5M Private Placement

Surrozen (SRZN) Announces $192.5M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Guggenheim Securities , Nasdaq Stock Market , Surrozen Inc , Exchange Commission , Column Group , Safety Review Committee , Company Nasdaq , Wnt Pathway , Nantahala Capital , Stonepine Capital Management , Stempoint Capital , Securities Act ,

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

Financing led by Sphera Healthcare with participation from new and existing healthcare-focused institutional investors$16.0 million in upfront gro. ....

United States , Mike Moyer , Oren Gilad , Aprea Therapeutics Inc , Maxim Group , Securities Exchange , Exchange Commission , Sphera Healthcare , Nantahala Capital , Exome Asset Management , Stonepine Capital Management , Synthetic Lethality , Securities Act , Securities Exchange Act , Financial Condition ,

Aprea Therapeutics (APRE) Announces Private Placement Financing of up to $34.0 Million

Aprea Therapeutics (APRE) Announces Private Placement Financing of up to $34.0 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Oren Gilad , Maxim Group , Aprea Therapeutics Inc , Exchange Commission , Aprea Therapeutics , Sphera Healthcare , Nantahala Capital , Exome Asset Management , Stonepine Capital Management , Synthetic Lethality , Securities Act ,

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds to provide funds to conduct clinical development of cytisinicline through New Drug Application submission. ....

New York , United States , British Columbia , United Kingdom , Nicole Jones , Us Department Of Health , National Youth Tobacco , Prospectus Department , Life Sciences Announces Pricing , Life Sciences Inc , Jonestrading Institutional Services , Health Consequences Of Smoking , Drug Administration , Capital Markets , Exchange Commission , Human Services , World Health Organization , Bio Partners , High School Students , Registered Direct Offering , Concurrent Private , New Drug Application , Life Sciences , Propel Bio Partners , Nantahala Capital , Street Capital Markets ,